All In MedTech

FDA Clearance Tracker · P990086-S001

HEALTHTRONICS OSSATRON

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 1, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 1, 2001

Approved

Time to decision

194 days

Received Oct 19, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990086-S001
Device name
HEALTHTRONICS OSSATRON
Applicant location
Alpharetta, GA
Received
Oct 19, 2000
Decided
May 1, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Postapproval Study Protocol
Original approval
P990086

Device type

Device class
Class III

Every decision under product code NBN

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE POST MARKET APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Sanuwave, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.